May 17, 2024 8:30am EDT Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
May 15, 2024 4:05pm EDT Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results